The Research Division of the Sleep Disorders Center
In addition, the Research Division is committed to identifying successful treatment strategies for a variety of sleep-related disorders. To this end, we are endeavoring to study the following:
(2) Sleep-related disorders as contributory causes for, or as risk factors of, Chronic Fatigue Syndrome.
(3) The cause(s) of CNS hypersomnolence, and to design novel diagnostic tools
to aid sleep disorder specialists in verifying CNS Hypersomnolence.
(4) The clinical efficaciousness of Sinequan (Doxepin) to treat chronic insomnia.
(2) Studying the molecular genetic basis of narcoleps and other sleep disorders.
The effect of snoring and sleep apnea on cardiovascular and autonomic function:
Jason H. Mateika Ph.D. and Neil Kavey M.D.
(2) the separate and combined effect that snoring and sleep apnea have on cardiovascular function during sleep.
(3) if the treatment of snoring individuals with essential hypertension leads to the reversal of some of the
cardiovascular alterations that are normally associated with hypertension.
(2) to provide insight into how nighttime alterations in autonomic and cardiovascular function eventually
lead to daytime hypertension.
(3) to determine if snoring and sleep apnea interact in an additive or multiplicative fashion to produce the
changes in cardiovascular and autonomic function that have been reported for individuals with obstructive sleep apnea.
(4) to provide the rationale for treating non-apneic normotensive and hypertensive snoring individuals.
(2) Non-snoring healthy individuals between the ages of 25-50.
(3) A heavy snorer between the ages of 25-50 who does not stop breathing during sleep, does not have trouble sleeping,
is not extremely overweight but does suffer from essential hypertension.
Additional information and inquiries about these studies can be directed to The Sleep Disorders Center Research Dept.
copyright © 2004 The Sleep Disorders Center at The NewYork-Presbyterian
Hospital
Member, American Academy of Sleep Medicine